Advanced Cell Technology plans to tread cautiously on the ground left vacant by the collapse of a South Korean scientist's claims to have cloned a human embryo, as David Cyranoski reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
Related links
Related links
Related links in Nature Research
Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres
Verdict: Hwang's human stem cells were all fakes
Korean scandal will have global fallout
Bush's policy stopped US gaining stem-cell lead
Related external links
Rights and permissions
About this article
Cite this article
No end in sight for stem-cell odyssey. Nature 439, 658–659 (2006). https://doi.org/10.1038/439658a
Published:
Issue Date:
DOI: https://doi.org/10.1038/439658a
This article is cited by
-
Rules tighten for stem-cell studies
Nature (2006)
